HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope.

Journal Article (Journal Article)

HIV-1 envelope (Env) mimetics are candidate components of prophylactic vaccines and potential therapeutics. Here we use a synthetic V3-glycopeptide ("Man9-V3") for structural studies of an HIV Env third variable loop (V3)-glycan directed, broadly neutralizing antibody (bnAb) lineage ("DH270"), to visualize the epitope on Env and to study how affinity maturation of the lineage proceeded. Unlike many previous V3 mimetics, Man9-V3 encompasses two key features of the V3 region recognized by V3-glycan bnAbs-the conserved GDIR motif and the N332 glycan. In our structure of an antibody fragment of a lineage member, DH270.6, in complex with the V3 glycopeptide, the conformation of the antibody-bound glycopeptide conforms closely to that of the corresponding segment in an intact HIV-1 Env trimer. An additional structure identifies roles for two critical mutations in the development of breadth. The results suggest a strategy for use of a V3 glycopeptide as a vaccine immunogen.

Full Text

Duke Authors

Cited Authors

  • Fera, D; Lee, MS; Wiehe, K; Meyerhoff, RR; Piai, A; Bonsignori, M; Aussedat, B; Walkowicz, WE; Ton, T; Zhou, JO; Danishefsky, S; Haynes, BF; Harrison, SC

Published Date

  • March 16, 2018

Published In

Volume / Issue

  • 9 / 1

Start / End Page

  • 1111 -

PubMed ID

  • 29549260

Pubmed Central ID

  • 29549260

Electronic International Standard Serial Number (EISSN)

  • 2041-1723

Digital Object Identifier (DOI)

  • 10.1038/s41467-018-03565-6


  • eng

Conference Location

  • England